pharmaphorum June 17, 2024
Two executives at a telehealth start-up have been arrested and are facing allegations of fraud involving the distribution of medicines for attention-deficit hyperactivity disorder (ADHD).
Ruthia He, the founder and chief executive of San Francisco-based Done Global, and the company’s clinical president David Brody have been charged with participating in a scheme to illegally distribute Adderall and other stimulant drugs used to treat ADHD over the internet, conspiring to commit healthcare fraud, and obstructing justice.
The Department of Justice estimates that they may have generated more than $100 million in revenue from the activity, which provided around 40 million pills to customers who paid for a monthly subscription, even if there was no medical need for them.
The service included...
Today's Sponsors
Today's Sponsor